LA
AVNS

Lucus Advisors’s Avanos Medical AVNS Stock Holding History

Lucus Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-10,749
Closed -$409K – 193
2017
Q1 		$409K Buy
+10,749
New +$419K 0.38% 114
2016
Q4 		– Sell
-11,556
Closed -$401K – 60
2016
Q3 		$401K Buy
+11,556
New +$405K 0.35% 37

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Lucus Advisors's AVNS Position: Q2 2017 in Review

Lucus Advisors sold out of Avanos Medical (AVNS) in Q2 2017, closing a stake of 10,749 shares — an estimated $409K sold.

Lucus Advisors first reported a position in AVNS in Q3 2016 and held it in 2 quarters. The position peaked at $409K in Q1 2017. 328 funds tracked by Wall St. Rank hold AVNS as of Q2 2017.

  • Lucus Advisors reported no remaining Avanos Medical position as of Q2 2017 after selling out during the quarter.
  • Lucus Advisors sold 10,749 Avanos Medical shares in Q2 2017, an estimated $409K.
  • Lucus Advisors first reported a position in Avanos Medical in Q3 2016 and held it in 2 quarters.
  • Lucus Advisors's Avanos Medical position peaked at $409K in Q1 2017.
  • 328 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2017.

Based on Lucus Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.